UBS Lowered Its PT For HCA Holdings To $36, Maintained Its Buy Rating

Published on Tue, 07/26/2011 - 15:26
By FNNO Staff in General Interest, HCA, analyst, business, finance investing, hca holdings, market, news, rating, stock, trading, ubs, Analyst Insight
analyst, business, finance investing, hca holdings, market, news, rating, stock, trading, ubs

UBS lowered its price target for HCA Holdings (NYSE:HCA) to $36 from $40 and maintained its buy rating on the stock.

UBS has a potential upside of 37.6% based on a current price of $16.72 and an average consensus analyst price target of $23.

UBS is currently below its 50-day moving average (MA) of $17.98 and below its 200-day MA of $17.92.

By FNNO Staff
fnnonline@gmail.com

Most Popular Video News